BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38373107)

  • 81. EpCAM
    Nicolazzo C; Gradilone A; Loreni F; Raimondi C; Gazzaniga P
    Dis Markers; 2019; 2019():1718920. PubMed ID: 31636732
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
    Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
    J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
    Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
    Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
    Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
    EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
    Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
    Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells.
    Chalfin HJ; Verdone JE; van der Toom EE; Glavaris S; Gorin MA; Pienta KJ
    Clin Genitourin Cancer; 2017 Jun; 15(3):e477-e481. PubMed ID: 28153390
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
    Kim MJ; Choi NY; Lee EK; Kang MS
    Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of different CTC subpopulations in non-small cell lung cancer.
    Hanssen A; Wagner J; Gorges TM; Taenzer A; Uzunoglu FG; Driemel C; Stoecklein NH; Knoefel WT; Angenendt S; Hauch S; Atanackovic D; Loges S; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2016 Jun; 6():28010. PubMed ID: 27302574
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1.
    Schehr JL; Schultz ZD; Warrick JW; Guckenberger DJ; Pezzi HM; Sperger JM; Heninger E; Saeed A; Leal T; Mattox K; Traynor AM; Campbell TC; Berry SM; Beebe DJ; Lang JM
    PLoS One; 2016; 11(7):e0159397. PubMed ID: 27459545
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.
    Franken A; Kraemer A; Sicking A; Watolla M; Rivandi M; Yang L; Warfsmann J; Polzer BM; Friedl TWP; Meier-Stiegen F; Stoecklein NH; Dayan D; Riethdorf S; Mueller V; Pantel K; Koch A; Hartkopf AD; Krawczyk N; Ruckhaeberle E; Niederacher D; Fehm T; Neubauer H
    Br J Cancer; 2023 May; 128(9):1742-1752. PubMed ID: 36823365
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker.
    Zhang X; Li H; Yu X; Li S; Lei Z; Li C; Zhang Q; Han Q; Li Y; Zhang K; Wang Y; Liu C; Mao Y; Wang X; Irwin DM; Guo H; Niu G; Tan H
    Cell Physiol Biochem; 2018; 48(5):1983-1994. PubMed ID: 30092594
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
    Huang HB; Ge MJ
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The utility of flow cytometry in the diagnostic work up of malignant effusions due to nonhematopoietic neoplasms.
    Wong-Arteta J; Rey M; Aragón L; Gil-Rodríguez E; Bujanda L
    Cytometry B Clin Cytom; 2020 Nov; 98(6):504-515. PubMed ID: 32506689
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Integrated system for detection and molecular characterization of circulating tumor cells.
    Takahashi Y; Shirai K; Ijiri Y; Morita E; Yoshida T; Iwanaga S; Yanagida M
    PLoS One; 2020; 15(8):e0237506. PubMed ID: 32790768
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The RareCyte® platform for next-generation analysis of circulating tumor cells.
    Kaldjian EP; Ramirez AB; Sun Y; Campton DE; Werbin JL; Varshavskaya P; Quarre S; George T; Madan A; Blau CA; Seubert R
    Cytometry A; 2018 Dec; 93(12):1220-1225. PubMed ID: 30277660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.